13 years 🥳 of Publication, 100k+ Stories, 30+ Countries
Search
The Latest News from All Areas of Deals
Latham & Watkins Advises Icosavax in US$1.1 Billion Acquisition by AstraZeneca
Icosavax, Inc. (Nasdaq: ICVX) has announced it has entered into a definitive agreement pursuant to which AstraZeneca, through an acquisition…
Latham & Watkins Advises Underwriters on Kinetik’s Upsized Secondary Offering of Common Stock
Kinetik Holdings Inc. (NYSE: KNTK) (Kinetik) has announced the pricing of an upsized underwritten secondary offering of 6,500,000 shares of…
Latham & Watkins Advises Occidental in US$12 Billion Acquisition of CrownRock
Occidental (NYSE: OXY) has announced it entered into a purchase agreement to acquire Midland-based oil and gas producer CrownRock L.P.,…
Latham & Watkins Advises Liquid AI in US$37.5 Million Seed Financing
Liquid AI, an artificial intelligence research and development company, has announced it raised US$37.5 million in a seed funding round…
Linklaters advises Novo Holdings and co-advises Novozymes on the European Commission’s Phase I conditional approval of its proposed merger with Chr. Hansen
Linklaters has advised Novo Holdings and co-advised Novozymes on the proposed merger between Novozymes A/S (‘Novozymes') and Christian Hansen A/S…
Linklaters advises on the inception of Nationwide’s innovative “stock and drop” programme
Linklaters has advised a panel of leading banks comprising Citi as Arranger and Dealer and Barclays, BNP Paribas, BofA Securities,…
